EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH)

Mirjana Grocic iD, Madison Nguyen, Arun J Sanyal

Diabetes, Obesity and Metabolism · 2026-04 · 28 (S2) · 3-18

DOI: 10.1111/dom.70662 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 31.03.2026. Verfasst von Mirjana Grocic und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, VCU School of Medicine, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Obesity, Non-alcoholic Fatty Liver Disease, Liver Diseases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stravitz-Sanyal Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excess adiposity and obesity are increasingly prevalent, with incidence rising in many parts of the world; both trigger a state of metabo‐inflammation in adipose tissue, creating a systemic milieu characterised by insulin resistance and pro‐inflammatory and fibrogenic states. Along with systemic inflammatory cues, perturbations in systemic and individual organ metabolic homeostasis result in metabolically driven cell stress, injury and death; this activates innate immune signals promoting fibrogenesis and organ dysfunction. The phenotype of end‐organ diseases is determined by the balance between metabo‐inflammatory signals and homeostatic restorative factors. Some of the key end‐organ diseases associated with obesity and metabo‐inflammation include atherosclerotic vascular disease, hypertension, type 2 diabetes mellitus, chronic kidney disease and heart failure with preserved ejection fraction. Metabolic dysfunction‐associated steatotic liver disease and steatohepatitis have recently been recognised as a part of a cluster of non‐communicable diseases that account for the majority of premature deaths worldwide. The epidemiology, biological relationships of obesity to MASLD, mechanistic relationships between MASLD and other non‐communicable diseases, and the clinical impact on patients are reviewed in this manuscript. We also include a basis for obesity‐oriented treatment to manage MASLD. In summary, we provide a rationale for a holistic approach to the care of individuals with MASLD with a focus on treating obesity as a root cause, while monitoring liver status to determine the need for additional liver‐targeted therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityNon-alcoholic Fatty Liver DiseaseLiver DiseasesHumansInsulin ResistancePrevalenceDiabetes Mellitus, Type 2Adipose TissueFatty Liver

Stichwörter der Autor:innen

GLP‐1 receptor agonistscardiovascular diseasecirrhosismetabolic dysfunction associated steatohepatitismetabolic dysfunction associated steatotic liver diseasemetabolic flexibilitymetabophenotypenon‐communicable diseasesobesitytype 2 diabetes mellitus

Autor:innen und Institutionen

  • Department of Internal Medicine, VCU School of Medicine, Richmond, Virginia, USA.
  • Department of Internal Medicine and Stravitz-Sanyal Institute for Liver, Disease and Metabolic Health, Richmond, Virginia, USA.

ORCID-Profile: Mirjana Grocic

Förderung

  • Stravitz-Sanyal Institute
  • National Institutes of Health

Zitieren

APA

Grocic, M., Nguyen, M., & Sanyal, A. J. (2026). Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH). Diabetes, Obesity and Metabolism, 28(S2), 3-18. https://doi.org/10.1111/dom.70662

Vancouver

Grocic M, Nguyen M, Sanyal AJ. Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH). Diabetes, Obesity and Metabolism. 2026;28(S2):3-18. doi:10.1111/dom.70662

BibTeX
@article{Grocic2026,
  author = {Grocic, Mirjana and Nguyen, Madison and Sanyal, Arun J},
  title = {Current Trends in the Epidemiology of Obesity and the Association Between Obesity and Metabolic Liver Disease (MASLD/MASH)},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {S2},
  pages = {3--18},
  doi = {10.1111/dom.70662}
}
Kostenlos starten →